Production (Stage)
Kyverna Therapeutics, Inc.
KYTX
$3.21
-$0.18-5.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.15% | -11.07% | -7.12% | -6.37% | 542.64% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.22% | 22.05% | 46.44% | -54.58% | 82.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.78% | -10.69% | -6.72% | -7.10% | 518.96% |
|
|
|||||
| Total Current Assets | -14.78% | -10.69% | -6.72% | -7.10% | 518.96% |
| Net Property, Plant & Equipment | -17.39% | -6.38% | -8.99% | -1.93% | 20.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.00% | 38.85% | 36.54% | 2.47% | -55.52% |
| Total Assets | -14.44% | -10.19% | -6.59% | -6.89% | 418.63% |
|
|
|||||
| Total Accounts Payable | 83.22% | -53.44% | 104.32% | -34.76% | 70.97% |
| Total Accrued Expenses | 90.74% | -34.98% | 16.10% | 37.87% | 18.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.01% | 0.23% | 1.58% | 4.09% | 27.33% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.37% | 8.94% | 31.97% | 7.38% | 10.10% |
|
|
|||||
| Total Current Liabilities | -1.37% | 8.94% | 31.97% | 7.38% | 10.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.06% | -17.35% | -15.08% | -14.02% | 15.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.71% | 4.31% | 23.23% | 2.12% | 11.43% |
|
|
|||||
| Common Stock & APIC | 0.41% | 0.27% | 0.67% | 0.26% | 11,182.38% |
| Retained Earnings | -16.94% | -16.59% | -18.01% | -17.70% | -19.62% |
| Treasury Stock & Other | -100.95% | -31.37% | 513.51% | -3,600.00% | -125.00% |
| Total Common Equity | -15.97% | -11.93% | -9.23% | -7.61% | 374.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.97% | -11.93% | -9.23% | -7.61% | 374.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.97% | -11.93% | -9.23% | -7.61% | 634.06% |
|
|
|||||